WHO/Europe

Tuberculosis action plan for WHO European Region 2016–2020

Implementing the consolidated action plan to prevent and combat multidrug- and extensively drug-resistant tuberculosis (M/XDR TB) in the WHO European Region since 2011, Member States have made several major achievements in prevention, control and care. More than 1 million TB patients have been cured, including 53 000 with MDR-TB. Key challenges remain, especially due to ongoing primary transmission, increasing resistance of strains and deadly TB and HIV co-infections. The expected effects of the new action plan for 2016–2020 include curing 1.4 million TB patients, preventing 1.7 million new cases and saving US$ 48 billion.

Read More →

Mobile health care for Ukraine

Since February this year, doctors and nurses trained by WHO to use a web-based patient health information and guidance tool on a handheld tablet have been providing primary health care services to people in eastern Ukraine. Through the tablet, medical professionals have access to urgent care protocols and procedures based on WHO norms and standards, tailored to the Ukrainian context. The tool was developed to provide people-centred, real-time, comprehensive information and guidance. It can also give early warnings through syndromic and disease surveillance mechanisms.

Read More →

WHO/Europe: Request for submission of good practices in health systems strengthening for prevention and care of M/XDR-Tuberculosis (TB)

In September 2011 the Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-Resistant Tuberculosis in the WHO European Region, 2011–2015 and its accompanying resolution EUR/R61/R7 were endorsed at the sixty-first session of the Regional Committee (Baku, Azerbaijan, 12–15 September 2011). 

Read More →

Workshop on use of bedaquiline to treat extensively drug-resistant tuberculosis (XDR-TB) in Belarus

The National Tuberculosis Programme (NTP) in Belarus, in collaboration with WHO and with the support of the United Nations Development Programme; the Global Fund to Fight AIDS, TB and Malaria (the Global Fund); and Médecins Sans Frontières, organized a workshop on "The use of bedaquiline to treat XDR-TB" on 7 May 2015 at the Republican Scientific and Practical Centre for Pulmonology and Tuberculosis in Minsk, Belarus. The training was conducted by WHO and national experts from NTP and the National Pharmacovigilance Centre and was attended by 28 participants. 

Read More →

Public consultation of new TB Action Plan for the WHO European Region 2016-2020

The Plan will be submitted for endorsement by the WHO Regional Committee for Europe in September 2015 along with an accompanying resolution.

Read More →

Riga Declaration paves the way to ending TB in the European Region

In her keynote speech at the 1st Eastern Partnership Ministerial Conference on Tuberculosis and Its Multi-Drug Resistance, held on 30–31 March in Riga, Latvia, Dr Zsuzsanna Jakab, WHO Regional Director for Europe, declared: "Europe is in a position to lead prevention, care and the innovation of new tools in the fight against TB, and to pave the way for TB elimination. It is only through regional collaboration and cooperation that we can achieve this goal, so that our children will live in a world free of TB." 

Read More →

New WHO report shows that transparency and cooperation help to reduce high prices for new medicines

As the number of new medicines introduced in Europe rises, governments are finding it increasingly difficult to afford them, according to a comprehensive study released today by the WHO Regional Office for Europe. The study illustrates the challenges for national health systems, with specific examples, and shows that few countries in the WHO European Region have mechanisms in place to evaluate the cost–effectiveness of new drugs; this hampers the value-assessment and decision-making processes.

Read More →

Each day 1000 people fall sick with tuberculosis in the European Region

Tuberculosis cases down by 6% in 2013 – pace too slow to reach elimination this century. Rates of MDR-TB remain at very high levels, making the European Region the most affected area of the entire world.

Read More →

Second Advisory Committee meeting for the new TB Action Plan of the WHO European Region, 2016–2020

The Joint Tuberculosis, HIV/AIDS and Hepatitis Programme (JTH) held the second meeting of the Advisory Committee for the new TB Action Plan of the WHO European Region, 2016–2020. The meeting was held on Wednesday 4 March 2015 at the Regional Office in Copenhagen, Denmark. The Committee includes representatives from high- and low-TB-incidence countries, patient representatives and key partner organizations, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) and WHO headquarters.The meeting was an important milestone for reviewing the strategic directions, targets and areas of interventions of the new Action Plan, as well as inputs received from the European Technical Advisory Group on Tuberculosis Control (TAG-TB) and the Regional Consultation meetings held at the Regional Office 25-27 November 2014. 

Read More →

Medical supplies from WHO reach Donetsk as part of UN aid convoy

Several metric tonnes of medical aid procured by WHO reached Donetsk in Ukraine this week as part of the convoy of humanitarian aid delivered by UN agencies. WHO’s contribution consisted of HIV and tuberculosis medical products, HIV test systems and drugs to treat infections in people with weak immunity.

Read More →

Page 2 of 4 · Total posts: 10

←First 1 2 3 Last→